Nexalin Technology NXL
NASDAQ NXL
$4.28 -0.07 (-1.61%)
As of: Sep 30, 2026 · 3:59 PM EDT

Nexalin Technology (NXL) EBITDA (2021 - 2026)

Updated

Nexalin Technology (NXL) recorded EBITDA of -$2.22 million in Q2 2026.

Analysis

Nexalin Technology (NXL) EBITDA (2021 - 2026) Analysis & Trends

On a TTM basis, Nexalin Technology's EBITDA came in at -$8.37 million as of Jun 30, 2026; for FY2023, it was -$5.69 million.

  • Across earlier years, EBITDA came in at -$1.83 million in FY2022 and -$6.02 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly EBITDA since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 2.75 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 1.19 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 2.49 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 1.53 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 555.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 1.23 Bn
10 Nexalin Technology 3.19 Mn -8.60 Mn 8,897.00 -2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.22 Mn
Mar 31, 2026 -2.11 Mn
Dec 31, 2023 -1.62 Mn
Sep 30, 2023 -2.41 Mn
Jun 30, 2023 -876,034.00
Mar 31, 2023 -778,632.00
Dec 31, 2022 -719,485.00
Sep 30, 2022 -293,059.00
Jun 30, 2022 -444,969.00
Mar 31, 2022 -374,983.00
Dec 31, 2021 -577,355.00
API Access

Nexalin Technology EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=NXL&period=max&api_key=YOUR_API_KEY